| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/25/2009 | WO2008067257A8 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 06/25/2009 | WO2008065506A3 Pharmaceutical compositions comprising nanoparticles comprising enteric polymers and casein |
| 06/25/2009 | WO2008046084A3 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 06/25/2009 | WO2007127396A8 Process for the synthesis of (+) and (-) -1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane |
| 06/25/2009 | WO2007075177A3 Antibiotics targeting mreb |
| 06/25/2009 | WO2006068829A9 Agents which regulate, inhibit, or modulate the activity and/or expression of lysyl oxidase (lox) and lox-like proteases as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies |
| 06/25/2009 | WO2006047312A3 COMPOSITIONS AND METHODS FOR MODULATING PGC-1β TO TREAT LIPID-RELATED DISEASES AND DISORDERS |
| 06/25/2009 | US20090165153 Modified gene-silencing RNA and uses thereof |
| 06/25/2009 | US20090163887 Odor control cellulose granules with quinone compounds |
| 06/25/2009 | US20090163721 Crystalline solids of carvedilol and processes for their preparation |
| 06/25/2009 | US20090163601 (r)-2-methyl-(2,5-dimethylphenyl)propanol and (s)-(2-methyl-2,5-dimethylphenyl)propanol |
| 06/25/2009 | US20090163600 Anti-Inflammatory Agent and Cancer-Preventive Agent Comprising Canolol or Prodrug Thereof and Pharmaceutical, Cosmetic and Food Comprising the Same |
| 06/25/2009 | US20090163599 Mif adsorbant |
| 06/25/2009 | US20090163597 Preparation for Iontophoresis |
| 06/25/2009 | US20090163596 Bimatoprost crystalline form I |
| 06/25/2009 | US20090163595 Method of Modulating Membrane Potential of a Cell |
| 06/25/2009 | US20090163594 Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors |
| 06/25/2009 | US20090163593 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists; pain, Parkinson's disease, multiple sclerosis, or Huntington's chorea; asthma |
| 06/25/2009 | US20090163592 Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 06/25/2009 | US20090163591 Use of sugar phosphates, sugar phosphate analogs, amino acids and/or amino acid analogs for modulating the glucolysis-enzyme complex, the malate asparate shuttle and/or the transaminases |
| 06/25/2009 | US20090163590 Process for producing refined avocado oil rich in triglycerides, and oil obtainable by said process |
| 06/25/2009 | US20090163589 calcium receptor antagonists such as 3-{3,4-Difluoro-5-[(R)-2-hydroxy-3-(2-indan-2-yl-1,1-dimethyl-ethylamino)-propoxyl]-phenyl}-propionic acid, used to increase serum parathyroid hormone levels in mammals |
| 06/25/2009 | US20090163588 Aniline derivatives as selective androgen receptor modulators |
| 06/25/2009 | US20090163587 Ester prodrugs of prostratin and related phorbol compounds |
| 06/25/2009 | US20090163586 Bis-(Sulfonylamino) Derivatives in Therapy 205 |
| 06/25/2009 | US20090163584 Therapeutic agent for renal failure |
| 06/25/2009 | US20090163583 Process and an Apparatus for Producing Episesamin-Rich Compositions |
| 06/25/2009 | US20090163581 Pharmaceutical Products for Treating Neoplastic Disease and Inflammation |
| 06/25/2009 | US20090163580 Anti-aging composition containing resveratrol and method of administration |
| 06/25/2009 | US20090163579 Novel use of nutraceutical compositions |
| 06/25/2009 | US20090163578 Novel modification of immunomodulatory protein |
| 06/25/2009 | US20090163577 METHODS AND COMPOSITIONS FOR ANTAGONIZING ANTI-APOPTOTIC Bcl-2-FAMILY PROTEINS |
| 06/25/2009 | US20090163576 Compounds for the treatment of metabolic disorders |
| 06/25/2009 | US20090163575 Solvent systems for pour-on formulations for combating parasites |
| 06/25/2009 | US20090163574 Stable Pharmaceutical Composition Containing Docetaxel and a Method of Manufacturing the Same |
| 06/25/2009 | US20090163573 Compositions and methods for enhancing protein accretion in skeletal muscle |
| 06/25/2009 | US20090163572 Cooling Compounds |
| 06/25/2009 | US20090163571 Pharmaceutical for use in the treatment of ureterolithiasis |
| 06/25/2009 | US20090163570 Bladder cancer treatment and methods |
| 06/25/2009 | US20090163568 Avermectin/metronidazole compositions for treating afflictions of the skin, e.g., rosacea |
| 06/25/2009 | US20090163566 Imidazole Derivatives and their use for Modulating the Gabaa Receptor Complex |
| 06/25/2009 | US20090163565 Compounds with nootropic action, their preperation, pharmaceutical compositions containing them, and use thereof |
| 06/25/2009 | US20090163564 Translational Dysfunction Based Therapeutics |
| 06/25/2009 | US20090163563 Phorboxazole Compounds and Methods of Their Preparation |
| 06/25/2009 | US20090163562 Oral composition comprising 3-[5-[4-(cyclopentyloxy) -2-hydroxybenzoyl]-2-[(3-hydroxy-1,2-benzisoxazol-6- yl)methoxy]phenyl]propionic acid or salt thereof |
| 06/25/2009 | US20090163561 Amorphous metaxalone and amorphous dispersions thereof |
| 06/25/2009 | US20090163560 5-(3-(2-(4-(1-Hydroxyhexyl)phenyl)-3-oxopyrazolidin-1-yl)propyl)thiophene-2-carboxylic acid; bioisosteres; vision defects; glaucoma; hypotensive agents; ocular hypertension; kits |
| 06/25/2009 | US20090163559 Estrogen receptor modulators |
| 06/25/2009 | US20090163558 Substituted Methyl Aryl or Heteroaryl Amide Compounds |
| 06/25/2009 | US20090163557 Cannabinergic Lipid Ligands |
| 06/25/2009 | US20090163556 Glycinamide derivatives as raf-kinase inhbitors |
| 06/25/2009 | US20090163555 Isolated optically active stereoisomers are useful for enhancing an immuneresponse, for treating autoimmune diseases and asantitumor agents, bacteriacides, fungicides or viricides; one pot synthesis of1-(3-a3S,5R-1-(3-amino-5-carboxy-2-oxopyrrolidin-3-ylmethyl)pyridinium bromide hydrobromide |
| 06/25/2009 | US20090163553 Benzimidazole compound crystal |
| 06/25/2009 | US20090163552 Carboxyl- or hydroxyl-substituted benzimidazole derivatives |
| 06/25/2009 | US20090163551 Compositions and Methods for Treating Diseases |
| 06/25/2009 | US20090163550 Retinoid-containing sustained release intraocular implants and related methods |
| 06/25/2009 | US20090163549 Pharmaceutical Composition Comprising an Amide Derivative |
| 06/25/2009 | US20090163548 Method of using and comopositions comprising immunomodulatory compounds for the treatment and management of myeloproliferative diseases |
| 06/25/2009 | US20090163547 Indene derivatives, their preparation and use as medicaments |
| 06/25/2009 | US20090163546 Diacylglycerol acyltransferase inhibitors |
| 06/25/2009 | US20090163545 Method For Altering The Lifespan Of Eukaryotic Organisms |
| 06/25/2009 | US20090163544 Use of NK-3 Receptor Antagonists for the Treatment of Nausea and Vomiting |
| 06/25/2009 | US20090163543 Histone Deacetylase Inhibitors and Methods of Use Thereof |
| 06/25/2009 | US20090163542 5-ht7 receptor antagonists |
| 06/25/2009 | US20090163541 Quinuclidine compounds having quaternary ammonium group, its preparation method and use as blocking agents of acetylcholine |
| 06/25/2009 | US20090163540 Quinine Sulfate Polymorphs, Processes of Preparing, Compositions and Uses Thereof |
| 06/25/2009 | US20090163539 Enantiomer of tenatoprazole and the use thereof in therapy |
| 06/25/2009 | US20090163538 Tetrahydropyridothiophenes For Use In The Treatment Of Cancer |
| 06/25/2009 | US20090163537 Thienopyridinone Compounds and Methods of Treatment |
| 06/25/2009 | US20090163536 Methods and compounds for treatment of clostridium based infection |
| 06/25/2009 | US20090163535 Substituted Heteroarylalkanoic Acids |
| 06/25/2009 | US20090163534 Indolizine Derivatives |
| 06/25/2009 | US20090163533 1-Substituted Pyrazolo (3,4-C) Ring Compounds as Modulators of Cytokine Biosynthesis for the Treatment of Viral Infections and Neoplastic Diseases |
| 06/25/2009 | US20090163532 Aqueous Gel Formulations Containing Immune Response Modifiers |
| 06/25/2009 | US20090163531 Use of Tiotropium Salts in the Treatment of Severe Persistent Asthma |
| 06/25/2009 | US20090163530 adapted to adhere to and dissolve in a mouth of a consumer include a water soluble film-forming polymer pullulan, antimicrobially effective amounts of essential oils thymol, methyl salicylate, eucalyptol and menthol; for killing plaque-producing germs that cause dental plaque, bad breath, gingivitis |
| 06/25/2009 | US20090163529 Identifying therapeutic compounds based on their physical-chemical properties |
| 06/25/2009 | US20090163528 Pharmaceutical composition having analgesic effects |
| 06/25/2009 | US20090163527 Spiropiperidines for use as tryptase inhibitors |
| 06/25/2009 | US20090163526 Process for the Preparation of an Anti Microbial Extract from Leaves of the Plant Callistemon Rigidus |
| 06/25/2009 | US20090163525 Substituted quinazolines with anti-cancer activity |
| 06/25/2009 | US20090163524 Novel Protein Kinase B Inhibitors - 060 |
| 06/25/2009 | US20090163523 Combinations comprising a s1p receptor agonist and a jak3 kinase inhibitor |
| 06/25/2009 | US20090163522 Derivatives of Pyrido[2,3-d]pyrimidine, the Preparation Thereof, and the Therapeutic Application of the Same |
| 06/25/2009 | US20090163521 Novel Pyrazolopyrimidinone Derivatives |
| 06/25/2009 | US20090163520 MNK1 or MNK2 Inhibitors |
| 06/25/2009 | US20090163519 Dosing regimen associated with long acting injectable paliperidone esters |
| 06/25/2009 | US20090163518 Novel Compounds |
| 06/25/2009 | US20090163517 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 06/25/2009 | US20090163515 Compounds Which Bind to the Active Site of Protein Kinase Enzymes |
| 06/25/2009 | US20090163514 Benzisoxazole piperazine compounds and methods of use thereof |
| 06/25/2009 | US20090163513 Process for ziprasidone using novel intermediates |
| 06/25/2009 | US20090163512 Spiroindolinone Derivatives |
| 06/25/2009 | US20090163511 Carboxamide, Sulfonamide and Amine Compounds and Methods for Using The Same |
| 06/25/2009 | US20090163510 Methods of Identifying and Treating Individuals Exhibiting Mutant SRC Kinase Polypeptides |
| 06/25/2009 | US20090163509 Method for healing a wound using an alpha-adrenergic antagonist |
| 06/25/2009 | US20090163508 Amide compound |
| 06/25/2009 | US20090163507 Synthesis of naturally occuring ecteinascidins and related compounds |
| 06/25/2009 | US20090163506 Urea-compounds active as vanilloid receptor antagonists for the treatment of pain |
| 06/25/2009 | US20090163505 Amino-heteroaryl-containing prokineticin 1 receptor antagonists |